Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
Background: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrospective study, we aimed to assess the TBZ effectiveness and adverse events (AEs) in Huntington disease (HD), vascular chorea, tics, dystonia, tardive oromandibular (OM) dyskinesia and other tardive syn...
| Prif Awduron: | , , , , , , |
|---|---|
| Fformat: | Erthygl |
| Iaith: | English |
| Cyhoeddwyd: |
SAGE Publishing
2017-02-01
|
| Cyfres: | Therapeutic Advances in Neurological Disorders |
| Mynediad Ar-lein: | https://doi.org/10.1177/1756285616677004 |